OR5AS1
gene geneOn this page
Summary
OR5AS1 (olfactory receptor family 5 subfamily AS member 1, HGNC:15261) is a protein-coding gene on chromosome 11q12.1, encoding Olfactory receptor 5AS1 (Q8N127). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 219447 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_001001921
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15261 |
| Approved symbol | OR5AS1 |
| Name | olfactory receptor family 5 subfamily AS member 1 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000181785 |
| Ensembl biotype | protein_coding |
| Entrez | 219447 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641320
RefSeq mRNA: 1 — MANE Select: NM_001001921
NM_001001921
CCDS: CCDS31516
Canonical transcript exons
ENST00000641320 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811637 | 56027654 | 56027712 |
| ENSE00003814237 | 56030391 | 56038191 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 77.72.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.72 | silver quality |
| bone marrow cell | CL:0002092 | 47.81 | gold quality |
| sural nerve | UBERON:0015488 | 47.59 | gold quality |
| cortical plate | UBERON:0005343 | 46.44 | gold quality |
| colonic epithelium | UBERON:0000397 | 44.74 | gold quality |
| bone marrow | UBERON:0002371 | 44.11 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.08 | gold quality |
| muscle tissue | UBERON:0002385 | 41.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 41.41 | gold quality |
| ventricular zone | UBERON:0003053 | 39.79 | gold quality |
| calcaneal tendon | UBERON:0003701 | 39.34 | gold quality |
| ganglionic eminence | UBERON:0004023 | 38.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 38.63 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 37.45 | gold quality |
| liver | UBERON:0002107 | 36.85 | gold quality |
| tonsil | UBERON:0002372 | 36.80 | gold quality |
| monocyte | CL:0000576 | 35.45 | gold quality |
| primary visual cortex | UBERON:0002436 | 35.36 | gold quality |
| leukocyte | CL:0000738 | 35.23 | gold quality |
| blood | UBERON:0000178 | 35.06 | gold quality |
| cortex of kidney | UBERON:0001225 | 33.84 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 33.70 | gold quality |
| urinary bladder | UBERON:0001255 | 33.61 | gold quality |
| kidney | UBERON:0002113 | 33.60 | gold quality |
| uterine cervix | UBERON:0000002 | 33.46 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.41 | gold quality |
| adrenal tissue | UBERON:0018303 | 33.25 | gold quality |
| right coronary artery | UBERON:0001625 | 33.20 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 32.54 | gold quality |
| placenta | UBERON:0001987 | 32.34 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-6 | yes | 3821.56 |
| E-GEOD-81547 | yes | 217.00 |
| E-MTAB-5061 | yes | 15.70 |
| E-ANND-3 | yes | 5.40 |
| E-MTAB-6678 | no | 1265.57 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or5as1 | ENSMUSG00000075158 |
| rattus_norvegicus | Or5as1 | ENSRNOG00000031356 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 5AS1 — Q8N127 (reviewed: Q8N127)
Alternative names: Olfactory receptor OR11-168
All UniProt accessions (2): A0A126GVD4, Q8N127
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001001921* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N127-F1 | 87.98 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 19 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, RAO_BOUND_BY_SALL4_ISOFORM_A, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, ZHANG_FH_DEFICIENT_RCC_C2_VS_OTHERS_UP
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (4): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| binding | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
264 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR5AS1 | LCE4A | Q5TA78 | 447 |
| OR5AS1 | TRIM48 | Q8IWZ4 | 436 |
| OR5AS1 | TRIM51 | Q9BSJ1 | 419 |
| OR5AS1 | ZNF737 | O75373 | 315 |
| OR5AS1 | KRTAP9-1 | A8MXZ3 | 301 |
| OR5AS1 | PTCRA | Q6ISU1 | 295 |
| OR5AS1 | COL7A1 | Q02388 | 248 |
| OR5AS1 | CFAP47 | Q6ZTR5 | 248 |
| OR5AS1 | CD72 | P21854 | 247 |
| OR5AS1 | KRTAP9-2 | Q9BYQ4 | 247 |
| OR5AS1 | POTEM | A6NI47 | 247 |
| OR5AS1 | DNAJC18 | Q9H819 | 239 |
| OR5AS1 | VWA3B | Q502W6 | 232 |
| OR5AS1 | HOXC11 | O43248 | 231 |
| OR5AS1 | FAM110C | Q1W6H9 | 222 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBTFL1 | OR5AS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBTFL1 | OR5AS1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): UBTFL1 (Two-hybrid)
ESM2 similar proteins: A6NCV1, A6NF89, A6NJZ3, A6NL08, A6NM76, O95221, P0C7N1, P0C7N5, P37070, P37071, P37072, Q15617, Q60886, Q6IEU7, Q8N127, Q8NGE1, Q8NGG0, Q8NGG8, Q8NGP8, Q8NGP9, Q8NGR8, Q8NGS9, Q8NGT0, Q8NGT1, Q8NGX3, Q8NH01, Q8NH10, Q8NH51, Q8NH69, Q8VEW5, Q8VF65, Q8VF66, Q8VF76, Q8VFD0, Q8VFD3, Q8VFK2, Q8VG02, Q8VG03, Q8VG04, Q8VG07
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
378 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:56030742:T:A | acceptor_gain | 0.8300 |
| 11:56030625:A:AG | acceptor_gain | 0.7700 |
| 11:56030626:G:GG | acceptor_gain | 0.7700 |
| 11:56030747:C:G | donor_gain | 0.7200 |
| 11:56030833:A:T | donor_gain | 0.6700 |
| 11:56030705:G:GT | donor_gain | 0.6600 |
| 11:56030429:G:GG | donor_gain | 0.6500 |
| 11:56030447:C:CG | donor_gain | 0.6400 |
| 11:56030747:CTG:C | acceptor_gain | 0.6300 |
| 11:56030427:GA:G | donor_gain | 0.6100 |
| 11:56030428:A:AG | donor_gain | 0.6000 |
| 11:56030537:TCGG:T | donor_gain | 0.5900 |
| 11:56030957:A:AG | donor_gain | 0.5800 |
| 11:56031052:GTG:G | donor_gain | 0.5800 |
| 11:56031054:G:GA | donor_gain | 0.5800 |
| 11:56030685:G:GT | donor_gain | 0.5700 |
| 11:56030891:TCC:T | donor_gain | 0.5700 |
| 11:56030433:T:G | donor_gain | 0.5600 |
| 11:56030624:TAGA:T | acceptor_gain | 0.5600 |
| 11:56030426:A:T | donor_gain | 0.5500 |
| 11:56030447:C:G | donor_gain | 0.5500 |
| 11:56030739:T:TA | acceptor_gain | 0.5500 |
| 11:56030831:GGAGA:G | donor_gain | 0.5500 |
| 11:56030832:GAGAG:G | donor_gain | 0.5500 |
| 11:56030955:T:TA | acceptor_gain | 0.5500 |
| 11:56030745:TGCTG:T | acceptor_gain | 0.5400 |
| 11:56030749:G:GC | acceptor_gain | 0.5400 |
| 11:56030608:A:AG | acceptor_gain | 0.5300 |
| 11:56030609:G:GG | acceptor_gain | 0.5300 |
| 11:56030988:A:AG | acceptor_gain | 0.5300 |
AlphaMissense
2126 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:56030452:T:C | F12L | 0.874 |
| 11:56030454:C:A | F12L | 0.874 |
| 11:56030454:C:G | F12L | 0.874 |
| 11:56030920:T:C | F168L | 0.853 |
| 11:56030922:T:A | F168L | 0.853 |
| 11:56030922:T:G | F168L | 0.853 |
| 11:56031289:A:C | S291R | 0.847 |
| 11:56031291:T:A | S291R | 0.847 |
| 11:56031291:T:G | S291R | 0.847 |
| 11:56030950:T:C | F178L | 0.846 |
| 11:56030952:C:A | F178L | 0.846 |
| 11:56030952:C:G | F178L | 0.846 |
| 11:56030947:T:C | F177L | 0.845 |
| 11:56030949:T:A | F177L | 0.845 |
| 11:56030949:T:G | F177L | 0.845 |
| 11:56030783:G:C | R122P | 0.821 |
| 11:56030908:T:C | F164L | 0.819 |
| 11:56030910:C:A | F164L | 0.819 |
| 11:56030910:C:G | F164L | 0.819 |
| 11:56031043:A:C | S209R | 0.806 |
| 11:56031045:C:A | S209R | 0.806 |
| 11:56031045:C:G | S209R | 0.806 |
| 11:56030500:T:C | F28L | 0.796 |
| 11:56030502:C:A | F28L | 0.796 |
| 11:56030502:C:G | F28L | 0.796 |
| 11:56030632:A:C | S72R | 0.796 |
| 11:56030634:C:A | S72R | 0.796 |
| 11:56030634:C:G | S72R | 0.796 |
| 11:56030509:T:C | F31L | 0.756 |
| 11:56030511:C:A | F31L | 0.756 |
dbSNP variants (sampled 300 via entrez): RS1000192472 (11:56034692 G>A), RS1000450315 (11:56035022 G>A), RS1000863382 (11:56026507 A>G), RS1001255701 (11:56029928 C>T), RS1001489094 (11:56037290 G>A,T), RS1001604001 (11:56030245 A>G), RS1001652451 (11:56034363 G>A,T), RS1001772845 (11:56027890 T>C), RS1001821139 (11:56036400 A>G), RS1001825263 (11:56027741 C>A,T), RS1001990750 (11:56031797 T>C), RS1002106422 (11:56026780 C>A), RS1002159032 (11:56026456 T>C), RS1002208347 (11:56031239 T>A,C), RS1002381306 (11:56026234 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.